Sana adds hypoimmunogenic stem cell tech from Harvard to its tool kit
By Elizabeth S. Eaton, Staff Writer | Mar 26, 2019 | 11:13 PM GMT
Building out its portfolio of cell and gene therapy tools, Sana licensed technology from Harvard University comprising methods to create stem cells that avoid triggering immune rejection when transplanted.
The hypoimmunogenic stem cells are derived
Read the full 346 word article
User Sign In
This article may not be distributed to non-subscribers
PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD